Earnings History Data for Pharming Group N.V. (PHAR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Pharming Group N.V.
Pharming Group N.V. is a commercial stage biopharmaceutical company. It engages in developing protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs. The company's product portfolio includes C1INH. Pharming Group N.V. is based in Leiden, The Netherlands.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24-10-2024 | PM | PHAR | Pharming Group N.V. | 599.72 | -0.02 | 0.00 | 0.05 | Pharming reports Q3 results [10/24/2024 4:21 AM] |
8.30 | -0.66 (-7.37%) |
8.38 | -0.58 (-6.47%) |
6.65 - 13.20 | 6,040 | 10,000 | 395 | ||
| 01-08-2024 | PM | PHAR | Pharming Group N.V. | 524.78 | -0.01 | 0.00 | 0.02 | Pharming GAAP EPS of -$0.002, revenue of $74.1M [8/1/2024 8:31 AM] |
7.63 | -0.70 (-8.40%) |
8.18 | -0.15 (-1.80%) |
6.65 - 16.71 | 2,373 | 10,000 | 756 | ||
| 08-05-2024 | PM | PHAR | Pharming Group N.V. | 652.62 | -0.19 | 0.00 | -0.17 | Pharming GAAP EPS of -$0.01 misses by $0.02, revenue of $55.6M misses by $14.47M [5/8/2024 6:29 AM] |
9.70 | 0.04 (0.41%) |
9.50 | -0.16 (-1.66%) |
9.27 - 16.71 | 1,220 | 0 | 200 | ||
| 14-03-2024 | PM | PHAR | Pharming Group N.V. | 783.10 | -0.03 | 0.05 | -0.19 | 10.92 | -0.19 (-1.71%) |
10.50 | -0.61 (-5.49%) |
9.65 - 17.81 | 2,643 | 0 | 2,237 | |||
|
|
||||||||||||||||||
| 26-10-2023 | PM | PHAR | Pharming Group N.V. | 702.90 | 0.05 | 0.13 | 0.13 | Pharming GAAP EPS of $0.01 beats by $0.005, revenue of $66.7M beats by $4.87M [10/26/2023 6:17 AM] |
10.92 | 0.52 (5.00%) |
11.14 | 0.74 (7.12%) |
9.00 - 17.81 | 6,904 | 0 | 381 | ||
| 11-05-2023 | PM | PHAR | Pharming Group N.V. | 809.28 | -0.17 | 0.00 | 0.05 | Pharming GAAP EPS of -$0.017, revenue of $42.54M [5/11/2023 11:59 AM] |
11.05 | -1.77 (-13.81%) |
0.0 | 0.0 (0.00%) |
6.10 - 17.81 | 10,635 | 0 | 0 | ||
| 27-10-2022 | PM | PHAR | Pharming Group | 627.00 | 0.13 | 0.02 | 0.00 | 9.50 | 0.33 (3.60%) |
0.0 | 0.0 (0.00%) |
6.10 - 12.98 | 128 | 0 | 0 | |||
|
|
||||||||||||||||||